Loading
Latest filing published 20 Apr 2026 for 티앤알바이오팹, €31k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by 정승교 on record concern 티앤알바이오팹, in the capacity of chief executive. Over a trading history stretching from 31 October 2025 to 14 April 2026, the count stands at 3 filings.
No open-market sale appears; the market trades are 3 purchases worth €31k. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 2 purchases and no sales.
The newest entry dates from 20 April 2026: an open-market purchase of €31k, in 티앤알바이오팹. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.